Article Versions Notes

Valent P, Akin C, Nedoszytko B, Bonadonna P, Hartmann K, Niedoszytko M, Brockow K, Siebenhaar F, Triggiani M, Arock M, et al. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. International Journal of Molecular Sciences. 2020; 21(23):9030. https://doi.org/10.3390/ijms21239030

Valent, Peter, Cem Akin, Boguslaw Nedoszytko, Patrizia Bonadonna, Karin Hartmann, Marek Niedoszytko, Knut Brockow, Frank Siebenhaar, Massimo Triggiani, Michel Arock, and et al. 2020. "Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine" International Journal of Molecular Sciences 21, no. 23: 9030. https://doi.org/10.3390/ijms21239030

Valent, P., Akin, C., Nedoszytko, B., Bonadonna, P., Hartmann, K., Niedoszytko, M., Brockow, K., Siebenhaar, F., Triggiani, M., Arock, M., Romantowski, J., Górska, A., Schwartz, L. B., & Metcalfe, D. D. (2020). Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine. International Journal of Molecular Sciences, 21(23), 9030. https://doi.org/10.3390/ijms21239030